ls-104
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Tyrosine-protein kinase JAK2INHIBITOR
JAK2 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
N#C/C(=C\C=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1- Mol. weight
- 320.35 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095023 ↗
- ChEMBLCHEMBL3544997 ↗
Also known as
- 2-(benzylaminocarbonyl)-3-(3,4-dihydroxystyryl)acrylonitrile
- ls 104
- ls-104
- ls-104
- ls-104
- ls104 cpd